Background: Neurocognitive functioning is an integral phenotype of 22q11.2 deletion syndrome relating to severity of psychopathology and outcomes. A neurocognitive battery that could be administered remotely to assess multiple cognitive domains would be especially beneficial to research on rare genetic variants, where in-person assessment can be unavailable or burdensome. The current study compares in-person and remote assessments of the Penn computerised neurocognitive battery (CNB).
Methods: Participants (mean age = 17.82, SD = 6.94 years; 48% female) completed the CNB either in-person at a laboratory (n = 222) or remotely (n = 162).
Results: Results show that accuracy of CNB performance was equivalent across the two testing locations, while slight differences in speed were detected in 3 of the 11 tasks.
Conclusions: These findings suggest that the CNB can be used in remote settings to assess multiple neurocognitive domains.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jir.13115 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!